Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Maprotiline hydrochloride [USP:JAN]
RN: 10347-81-6
UNII: 7C8J54PVFI
InChIKey: NZDMFGKECODQRY-UHFFFAOYSA-N

Note

  • A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.

Molecular Formula

  • C20-H23-N.Cl-H

Molecular Weight

  • 313.8696
 

Classification Codes

  • Antidepressant
  • Drug / Therapeutic Agent
  • Human Data
  • Reproductive Effect
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Maprotiline hydrochloride [USP:JAN]

Synonyms

  • 1-(3-Methylaminopropyl)dibenzo(b,e)bicyclo(2.2.2)octadiene hydrochloride
  • 9-(gamma-Methylaminopropyl)-9,10-dihydro-9,10-ethanoanthracene hydrochloride
  • BA 34276
  • Ciba 34276 Ba
  • EINECS 233-758-8
  • Ludiomil
  • Maprotiline HCl
  • Maprotiline hydrochloride
  • N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine hydrochloride
  • N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine hydrochloride
  • Psymion
  • UNII-7C8J54PVFI

Systematic Names

  • 9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-, hydrochloride
  • 9,10-Ethanoanthracene-9(10H)-propylamine, N-methyl-, hydrochloride
  • Maprotiline hydrochloride

Registry Numbers

CAS Registry Number

  • 10347-81-6

FDA UNII

  • 7C8J54PVFI

Related Registry Number

  • 10262-69-8 (Parent)

System Generated Number

  • 0010347816

Molecular Formulas

Molecular Formula

  • C20-H23-N.Cl-H

Molecular Formula Fragments

  • C20-H23-N
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

InChI=1S/C20H23N.ClH/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20;/h2-5,7-10,15,21H,6,11-14H2,1H3;1H

InChIKey

NZDMFGKECODQRY-UHFFFAOYSA-N

Smiles

Cl.CNCCCC12CCC(c3ccccc13)c4ccccc24

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LDLo intravenous 30mg/kg (30mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION		 Bollettino Chimico Farmaceutico. Vol. 112, Pg. 601, 1973.
cat LDLo oral > 300mg/kg (300mg/kg)   Bollettino Chimico Farmaceutico. Vol. 112, Pg. 601, 1973.
child TDLo oral 12mg/kg (12mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 American Journal of Emergency Medicine. Vol. 6, Pg. 247, 1988.
dog LDLo intravenous 20mg/kg (20mg/kg)   Bollettino Chimico Farmaceutico. Vol. 112, Pg. 782, 1973.
dog LDLo oral 20mg/kg (20mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Bollettino Chimico Farmaceutico. Vol. 112, Pg. 601, 1973.
human TDLo oral 17mg/kg (17mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: GENERAL ANESTHETIC

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"		 British Medical Journal. Vol. 1, Pg. 1573, 1977.
man TDLo oral 490ug/kg (0.49mg/kg) BEHAVIORAL: SLEEP Journal of Clinical Psychiatry. Vol. 47, Pg. 210, 1986.
man TDLo oral 391mg/kg/1Y-I (391mg/kg) KIDNEY, URETER, AND BLADDER: INCONTINENCE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Postgraduate Medical Journal. Vol. 55, Pg. 742, 1979.
mouse LD50 intraperitoneal 125mg/kg (125mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 229, Pg. 163, 1977.
mouse LD50 intravenous 31mg/kg (31mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Bollettino Chimico Farmaceutico. Vol. 112, Pg. 601, 1973.
mouse LD50 oral 480mg/kg (480mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION

BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 1, Pg. 207, 1975.
mouse LD50 subcutaneous 310mg/kg (310mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 1, Pg. 207, 1975.
rabbit LDLo intravenous 20mg/kg (20mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION		 Bollettino Chimico Farmaceutico. Vol. 112, Pg. 601, 1973.
rabbit LDLo oral > 1gm/kg (1000mg/kg)   Bollettino Chimico Farmaceutico. Vol. 112, Pg. 601, 1973.
rat LD50 intraperitoneal 72mg/kg (72mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION		 Bollettino Chimico Farmaceutico. Vol. 112, Pg. 601, 1973.
rat LD50 intravenous 35mg/kg (35mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: MUSCLE WEAKNESS		 Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 1, Pg. 207, 1975.
rat LD50 oral 760mg/kg (760mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION		 Bollettino Chimico Farmaceutico. Vol. 112, Pg. 601, 1973.
rat LD50 subcutaneous 170mg/kg (170mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Bollettino Chimico Farmaceutico. Vol. 112, Pg. 601, 1973.
women LDLo oral 90mg/kg (90mg/kg) BEHAVIORAL: COMA Journal of Analytical Toxicology. Vol. 6, Pg. 199, 1982.
women TDLo oral 7mg/kg/1W-I (7mg/kg) BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) Journal of Clinical Pyschopharmacology. Vol. 3, Pg. 264, 1983.
women TDLo oral 20mg/kg (20mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)		 American Journal of Emergency Medicine. Vol. 2, Pg. 144, 1984.
women TDLo oral 63mg/kg/6W-I (63mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: GENERAL ANESTHETIC

KIDNEY, URETER, AND BLADDER: INCONTINENCE		 Postgraduate Medical Journal. Vol. 55, Pg. 742, 1979.
women TDLo oral 75mg/kg (75mg/kg) BEHAVIORAL: COMA

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP		 Intensive Care Medicine. Vol. 11, Pg. 220, 1985.